drugset / Trial / NCT02657031

The CHECK Trial: A Comparison of Headache Treatment in the ED: Compazine Versus Ketamine

NCT02657031

Phase 4 Completed 54 enrolled University Medical Center of Southern Nevada
RandomizedParallel-groupDouble-blindTreatment

Summary

This study compares the efficacy of low dose Ketamine versus Compazine for the control of headache in patients presenting to the Emergency Department.

Timeline

Start
2016-03-17
Primary completion
2017-03-21
Completion
2017-03-21

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Ketamine Small molecule 0.3 mg/kg Intravenous
Comparator Prochlorperazine Small molecule 10 mg Intravenous
Comparator Diphenhydramine Unknown 25 mg Intravenous
Background Ondansetron Other / unclassified 4 mg Intravenous

Indications